Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Macrocyclic compounds as ROS1 kinase inhibitors

Macrocyclic compounds as ROS1 kinase inhibitors

US Patent 10966985 · Granted Apr 6, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted quinoxaline compounds as inhibitors of FGFR tyrosine kinases2025
Protein tyrosine phosphatase inhibitors2025
Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of FGFR tyrosine kin2024
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors2024
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors2024
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors2024
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors2024
RET kinase inhibitors2024
RET kinase inhibitors2024
Compounds useful for inhibiting RET kinase2024
Compounds useful for inhibiting RET kinase2024
Fused heterocyclic compounds as RET kinase inhibitors2024